Science and Research

The Science and Research team at Tallac Therapeutics is dedicated to driving the discovery and preclinical development of novel immunotherapy candidates using the TRAAC platform. This team, comprising experts in clinical sciences, preclinical development, biologics discovery, and translational research, collaborates to advance the company's pipeline of TLR9 agonist-based therapies. They focus on rigorous scientific research, biomarker development, and translational strategies to ensure potent and targeted immune activation against cancer.